ATE267193T1 - Neue pyridazine als endothelin-antagonisten - Google Patents

Neue pyridazine als endothelin-antagonisten

Info

Publication number
ATE267193T1
ATE267193T1 AT01307528T AT01307528T ATE267193T1 AT E267193 T1 ATE267193 T1 AT E267193T1 AT 01307528 T AT01307528 T AT 01307528T AT 01307528 T AT01307528 T AT 01307528T AT E267193 T1 ATE267193 T1 AT E267193T1
Authority
AT
Austria
Prior art keywords
endothelin antagonists
new pyridazine
endothelin
pyridazine
new
Prior art date
Application number
AT01307528T
Other languages
English (en)
Inventor
Bernard Joseph Banks
Nathan Anthony Logan Chubb
Douglas James Critcher
James John Eshelby
Darren John Schulz
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE267193T1 publication Critical patent/ATE267193T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
AT01307528T 2000-09-20 2001-09-05 Neue pyridazine als endothelin-antagonisten ATE267193T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0023074.8A GB0023074D0 (en) 2000-09-20 2000-09-20 Pyridazines

Publications (1)

Publication Number Publication Date
ATE267193T1 true ATE267193T1 (de) 2004-06-15

Family

ID=9899818

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01307528T ATE267193T1 (de) 2000-09-20 2001-09-05 Neue pyridazine als endothelin-antagonisten

Country Status (12)

Country Link
EP (1) EP1191026B1 (de)
JP (1) JP3545735B2 (de)
AT (1) ATE267193T1 (de)
BR (1) BR0104141A (de)
CA (1) CA2357687C (de)
DE (1) DE60103342T2 (de)
DK (1) DK1191026T3 (de)
ES (1) ES2220677T3 (de)
GB (1) GB0023074D0 (de)
MX (1) MXPA01009174A (de)
PT (1) PT1191026E (de)
TR (1) TR200401185T4 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2471220C (en) * 2002-01-02 2010-11-16 Actelion Pharmaceuticals Ltd Novel alkansulfonamides as endothelin antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0096657B1 (de) * 1982-06-08 1989-04-05 Ciba-Geigy Ag 2-Phenyl-, 2-Naphthyl- und 2-Heterocyclylpyrimidine als Gegenmittel zum Schützen von Kulturpflanzen vor durch Herbizide verursachte phytotoxische Schäden
US5707966A (en) * 1994-03-04 1998-01-13 Eli Lilly And Company Antithrombotic agents
DE19537548A1 (de) * 1995-10-09 1997-04-10 Merck Patent Gmbh Endothelin-Rezeptor-Antagonisten
EP0882719B1 (de) * 1995-12-20 2001-05-16 Yamanouchi Pharmaceutical Co. Ltd. Arylethensulfonamid-derivate und diese enthaltende medikamente

Also Published As

Publication number Publication date
EP1191026A1 (de) 2002-03-27
BR0104141A (pt) 2002-07-09
JP3545735B2 (ja) 2004-07-21
DE60103342D1 (de) 2004-06-24
CA2357687A1 (en) 2002-03-20
GB0023074D0 (en) 2000-11-01
PT1191026E (pt) 2004-10-29
TR200401185T4 (tr) 2004-06-21
EP1191026B1 (de) 2004-05-19
CA2357687C (en) 2006-03-14
DK1191026T3 (da) 2004-06-28
DE60103342T2 (de) 2004-09-23
JP2002128780A (ja) 2002-05-09
ES2220677T3 (es) 2004-12-16
MXPA01009174A (es) 2004-10-15

Similar Documents

Publication Publication Date Title
ATE314371T1 (de) Spiro-indole als y5-rezeptor antagonisten
DE60126785D1 (de) Nicht-imidazol aryloxypiperidine als h3 rezeptor liganden
ATE268324T1 (de) 4-amino substituierte -2-subsituierte-1,2,3,4- tetrahydrochinoline als cetp inhibitoren
DE60139021D1 (de) Piperazinylpyrazinverbindungen als antagonisten des serotonin-5-ht2-rezeptors
ATE286897T1 (de) Morpholinderivate als antagonisten an orexinrezeptoren
BRPI0413022A (pt) derivados de 3-amino cromado e 2-amino tetralina
ATE422198T1 (de) Arylsulfonylnaphthalinderivate als 5ht2a- antagonisten
DE60131971D1 (de) 1,3,8-TRIAZA-SPIROi4,5 DECAN-4-ONDERIVATIVE ALS NEUROKININREZEPTORANTAGONISTEN
EA200201119A1 (ru) Лиганды меланокортиновых рецепторов
DE69910831D1 (de) Epothilonderivate und ihre verwendung als antitumormittel
DE602006007556D1 (de) Heteroarylsulfonylstilbene als 5-ht2a-antagonisten
ATE319696T1 (de) Nicht-imidazol aryloxyalkylamine als h3 rezeptor liganden
PT1353689E (pt) Composicoes imunizantes e metodos de utilizacao
DE59904535D1 (de) Neue Benzonaphtyridin-N-oxide
ATE300543T1 (de) Kondensierte pyrazindionderivate als pde5 inhibitore
ATE296809T1 (de) 3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p38-kinase-inhibitoren
DE60100620D1 (de) Gezielte elektrochemische reduktion von halogenierten 4-amino-picolinsäuren
ATE411287T1 (de) Neue metallproteinaseinhibitoren
DE602006008937D1 (de) N-amidderivate von 8-azabicycloä3.2.1üoct-3-yl als ccr1-antagonisten
DE60015599D1 (de) 3,4-DIHYDRO-(1H)CHINAZOLIN-2-ON-VERBINDUNGEN ALS CSBP/p38-KINASE-INHIBITOREN
DE60230491D1 (de) Als ccr5-antagonisten verwendbare aryloxim-piperazine
ATE464893T1 (de) N,n'-diarylguanidine als il-8-rezeptor- antagonisten
NO20031033D0 (no) Reseptor i EDb-fibronectindomene
ATE267193T1 (de) Neue pyridazine als endothelin-antagonisten
DE602004015028D1 (de) Protomikroemulsion, diese enthaltendes reinigungsgerät und verwendung von diesen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1191026

Country of ref document: EP

REN Ceased due to non-payment of the annual fee